Key facts
- This page summarizes Jonathan D. Root's Form 4 filing for Inari Medical, Inc..
- 3 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 27 May 2022, 16:26.
Jonathan D. Root - 26 May 2022 Form 4 Insider Report for Inari Medical, Inc.
- Reporting relationship
- Director
- Issuer ticker
- N/A
- Reported as of
- 26 May 2022
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 27 May 2022, 16:26:57 UTC
- Prior SEC filing
- 28 Feb 2022
- Next SEC filing
- 13 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Angela Ahmad, attorney-in-fact for Jonathan Root, M.D.
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jonathan D. Root filed Form 4 for Inari Medical, Inc. on 27 May 2022.
Change
- Previous filing in this sequence was filed on 28 Feb 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NARI
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +2,420
- Change %
- +0.46%
- Price
- $0.000000
- Shares after
- 528,646
- Date
- 26 May 2022
- Ownership
- Direct
- Footnotes
- F1
NARI
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +2,983
- Change %
- +0.56%
- Price
- $0.000000
- Shares after
- 531,629
- Date
- 27 May 2022
- Ownership
- Direct
NARI
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 335
- Date
- 26 May 2022
- Ownership
- Directly Owned by Spouse
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NARI
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -2,983
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 2,982
- Date
- 27 May 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 2,983
- Exercise price
- $0.000000
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Represents RSUs granted on May 26, 2022, to the Reporting Person that vest in full on the earlier to occur of (i) the one-year anniversary of the grant date and (ii) the date of the 2023 annual meeting.
Footnote F2
The Reporting Person was granted restricted stock units ("RSUs") which represent a contingent right to receive one share of common stock for each RSU. 1/3 of the RSUs vested on May 27,2021, and the remaining RSUs will vest annually thereafter over the next two years.